Working… Menu

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer (MC2TCR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04729543
Recruitment Status : Recruiting
First Posted : January 28, 2021
Last Update Posted : January 28, 2021
Ludwig Institute for Cancer Research
Dutch Cancer Society
Stichting Coolsingel Rotterdam grant
Jan Ivo Stichting grant
Information provided by (Responsible Party):
A.A.M. van der Veldt, Erasmus Medical Center